General Information
Revision date
2010-12-17
Product name
DMP: Dimethyl Pimelimidate Dihydrochloride
Product Synonyms
dimethyl heptane-1,7-diimidate dihydrochloride Ingestion : No specific data
CAS No.
58537-94-3
1.2.1 Relevant identified uses
Refer to the instruction 800.424.9300 booklet for proper and OUTSIDE US
supplier name
Thermo Fisher Scientific
Manufacturer Name
Thermo Fisher Scientific
Icons in SDS
Company Information
company name
Thermo Fisher Scientific
GHS Information
Signal word
WARNING!
Hazard Codes
Hazard statements (CLP)
H228, H350i
Hazard statements
Code
Statements
H228
Flammable solid
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Emergency overview Physical state Solid. [Powder.] Color White.
Signal word
WARNING!
Hazard statements
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.
Precautionary statements
Avoid breathing dust. Use only with adequate ventilation. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Wash thoroughly after handling. OSHA/IHCS status This material
Principle Routes of Exposure
Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion No known significant effects or critical hazards. Skin Irritating to skin. Eyes Irritating to eyes.
Potential chronic health
effects Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. 12/17/2010. 1/8 Life Science Research PO Box 117 Rockford, IL (815) 968-0747 www.thermo.com Pierce Biotechnology Inc. 3747 N. Meridian Road 61105 (815) 968-7316 Fax DMP: Dimethyl Pimelimidate Dihydrochloride Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness Medical conditions None known. aggravated by over- exposure See toxicological information (Section 11)
